Scale-up Systems establishes new office in India

NewsGuard 100/100 Score

Scale-up Systems Limited, the leading provider of process development software to the pharmaceutical industry, today announced it has established Scale-up Systems India Pvt. Ltd., a Mumbai-based subsidiary that will support its growing number of customers in India.

Scale-up Systems India Pvt. Ltd. will be building on business relationships developed over the past three years with leading Indian pharmaceutical and speciality chemicals companies. Following the success of the first Indian DynoChem User Meeting in April 2011, a dedicated local presence has become necessary to provide rollout support and closer communication with Indian managers and users.

An initial team in the Mumbai office will be led by Mr. Mahendra Pandit on the Business side and Dr. Sanket Salgaonkar for Training & Technical Support.

Scale-up Systems India's Managing Director Dr. Steve Hearn said "For us, the Indian market represents an exciting combination of increased investment and presence from Big Pharma, growing indigenous companies that are hungry to succeed and Universities that are producing extremely capable young chemists and engineers. These factors bode well for those companies whose management embrace the reality that strong process understanding is critical to meet today's regulatory and business requirements."

For further information, please visit www.scale-up.com.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
DELiVR's virtual reality training speeds up cell detection in complex brain datasets